ENDRA Life Sciences Inc. (NDRA)
NASDAQ: NDRAHealthcareDiagnostics & ResearchUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
NDRA stock chart
Technical analysisKey statistics
All statistics- Market cap
- $8.89M
- EPS (TTM)
- -$6.26
- Dividend yield
- None
- 52-week range
- 2.96 – 9.85
- Day range
- 5.81 – 6.48
- Volume / Avg
- 12.89K / 34.65K
- Beta
- —
- Shares outstanding
- 1.50M
52-week range
NDRA stock today
ENDRA Life Sciences (NDRA) closed at $5.93 on Oct 8, down 2.15% (-$0.13), versus the S&P 500's 0.47% decline. Trading was light, with 12.89K shares changing hands, about 37% of the average daily volume. Shares are 39.8% below their 52-week high of $9.85 and 100.3% above the 52-week low of $2.96, in the middle of the past year's range.
ENDRA Life Sciences has posted a net loss over the last twelve months (EPS of -$6.26), so its P/E ratio is not meaningful.
Summary generated from market data by MetaCap's automated system. Methodology
About ENDRA Life Sciences
Company profileENDRA Life Sciences Inc. develops technologies to improve the capabilities of clinical diagnostic ultrasound. The company is involved in the development of thermo-acoustic enhanced ultrasound technology that uses pulsed energy source such as radio frequency to transmit energy deep into tissue and generate ultrasonic waves to create high-contrast images for use in the treatment of non-alcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and tissue perfusion analysis.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- CEO
- Mr. Alexander Y. Tokman
- Headquarters
- Ann Arbor, MI
- Employees
- 9
- IPO year
- 2017
- Website
- endrainc.com
Analyst forecast
ForecastConsensus
none
Avg. price target
$25.00+321.59%
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
ENDRA Life Sciences peers
Healthcare sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| XWELXWELL Inc. | 0.9189 | +1.87% | $7.89M | vs NDRA |
| ADVBAdvanced Biomed Inc. | 6.12 | -2.86% | $10.11M | vs NDRA |
| BIAFbioAffinity Technologies Inc. | 5.64 | -8.44% | $6.58M | vs NDRA |
| ISPCiSpecimen Inc. | 1.09 | -0.91% | $2.75M | vs NDRA |
| PRPOPrecipio Inc. | 23.19 | -1.40% | $41.51M | vs NDRA |
| MDXHMDxHealth SA | 0.5805 | -3.22% | $55.39M | vs NDRA |
| IMDXInsight Molecular Diagnostics Inc. | 3.28 | -5.20% | $107.34M | vs NDRA |
| BNRBurning Rock Biotech Limited ADR | 15.20 | +0.13% | $160.30M | vs NDRA |
Indexes, lists and sector
Appears in lists
ENDRA Life Sciences stock FAQ
What is ENDRA Life Sciences's stock price today?
NDRA last traded at $5.93 as of Oct 8, 4:00 PM EDT, down 2.15% on the day. Prices are delayed at least 15 minutes.
Who is ENDRA Life Sciences's CEO?
Mr. Alexander Y. Tokman is the chief executive officer of ENDRA Life Sciences Inc., which has about 9 employees.
What is the NDRA 52-week high?
The 52-week high for NDRA is $9.85 and the 52-week low is $2.96. The stock is currently 39.8% below its high.